## References

1.International Agency for Research on Cancer (IARC) (2014) Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon, France: WHO Press.

2.Centers for Disease Control and Prevention (1998) Helicobacter pylori: Fact Sheet for Health Care Providers.

3.Goodman, KJ, et al. (1996) *Helicobacter pylori* infection in the Colombian Andes: a population-based study of transmission pathways. American Journal of Epidemiology 144, 290–299.

4.Neale, KR and Logan, RP (1995) The epidemiology and transmission of *Helicobacter pylori* infection in children. Alimentary Pharmacology & Therapeutics 9, 77–84.

5.Koletzko, S and Mégraud, F. (2016) *Helicobacter pylori* infection in children. In Backert, S, Yamaoka, Y (eds). Helicobacter pylori Research: From Bench to Bedside. Japan: Springer, pp. 443–467.

6.Kim, N. (2016) Prevalence and transmission routes of *H. pylori*. In Kim, N (ed.). Helicobacter pylori. Singapore: Springer. pp. 3–19.

7.Eusebi, LH, Zagari, RM and Bazzoli, F (2014) Epidemiology of *Helicobacter pylori* infection. Helicobacter 19, 1–5.

8.Perry, S, et al. (2006) Gastroenteritis and transmission of *Helicobacter pylori* infection in households. Emerging Infectious Diseases 12, 1701–1708.

9.Rowland, M, et al. (2006) Age-specific incidence of *Helicobacter pylori*. Gastroenterology 130, 65–72.

10.Malaty, HM, et al. (2002) Age at acquisition of *Helicobacter pylori* infection: a follow-up study from infancy to adulthood. Lancet 359, 931–935.

11.Kim, SS, et al. (2011) *Helicobacter pylori* in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Letters Elsevier Ireland Ltd 305, 228–238.

12.Wroblewski, LE, Peek, RM and Wilson, KT (2010) *Helicobacter pylori* and gastric cancer: factors that modulate disease risk. Clinical Microbiology Reviews 23, 713–739.

13.Goss, PE, et al. (2013) Planning cancer control in Latin America and the Caribbean. The Lancet Oncology 14, 391–436.

14.Torres, J, et al. (2016) Population-based strategies for *Helicobacter pylori*-associated disease management: Latin American perspective. In Backert, S, Yamaoka, Y (eds). Helicobacter pylori Research: From Bench to Bedside. Japan: Springer, pp. 503–517.

15.Torres, J, et al. (1998) A community-based seroepidemiologic study of *Helicobacter pylori* infection in Mexico. The Journal of Infectious Diseases 178, 1089–1094.

16.Hens, N, et al. (2010) Seventy-five years of estimating the force of infection from current status data. Epidemiology and Infection 138, 802–812.

17.Brisson, M, Edmunds, WJ and Gay, NJ (2003) Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 70, 31–37.

18.Anderson, RM and May, R. (1991) Infectious Diseases of Humans: Dynamics and Control. Oxford, UK: Oxford University Press.

19.Parsonnet, J. (2003) What is the *Helicobacter pylori* global reinfection rate? Canadian Journal of Gastroenterology 17(Suppl. B), 46–49.

20.Rupnow, MFT, et al. (2000) A dynamic transmission model for predicting trends in *Helicobacter pylori* and associated diseases in the United States. Emerging Infectious Diseases 6, 228–237.

21.Farrington, CP (1990) Modelling forces of infection for measles, mumps and rubella. Statistics in Medicine 9, 953–967.

22.Muench, H. (1959) Catalytic Models in Epidemiology. Cambridge, MA: Harvard University Press.

23.Tapia, R, Gutiérrez, G and Sepúlveda, J (1992) Metodología de la encuesta nacional seroepidemiológica. Salud Pública de México 34, 124–135.

24.Espinoza Monje, M and Marin Vega, A. (2016) *Helicobacter pylori* and perinatal pathologies: pathogen transmission during childbirth? Biology and Medicine 8, Published online: 2016. doi: 10.4172/0974-8369.1000313.

25.Gelman, A and Hill, J. (2006) Data Analysis Using Regression and Multilevel/Hierarchical Models. New York, NY: Cambridge University Press.

26.Greenland, S (2000) Principles of multilevel modelling. International Journal of Epidemiology 29, 158–167.

27.Witte, JS, et al. (1994) Hierarchical regression analysis applied to a study of multiple dietary exposures and breast cancer. Epidemiology 5, 612–621.

28.Plummer, M. (2003) JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling. In Hornik, K, Leish, F, Zeileis, A (eds). Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003). Vienna, Austria: Achim Zeileis.

29.Duque, X, et al. (2012) Natural history of *Helicobacter pylori* infection in Mexican schoolchildren: incidence and spontaneous clearance. Journal of Pediatric Gastroenterology and Nutrition 55, 209–216.

30.Goodman, KJ, et al. (2005) Dynamics of *Helicobacter pylori* infection in a US-Mexico cohort during the first two years of life. International Journal of Epidemiology 34, 1348–1355.

31.Hens, N, et al. (2012) Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: A Modern Statistical Perspective. New York, NY: Springer.

32.González-Piñera, JG, et al. (1998) Macrólidos. Acta Medica 8, 71–74.

33.Sacre Hazouri, JA (2006) Artículo de revisión Macrólidos. Efectos antinflamatorios e inmunomoduladores. Indicación en enfermedades respiratorias. Revista Alergia Mexico 53, 108–122.

34.Dirección de Información Epidemiológica (2011) Perfil epidemiológico de los tumores malignos en México. Mexico City, Mexico: Secretaría de Salud.

35.Moran, PAP (1948) The interpretation of statistical maps. Journal of the Royal Statistical Society. Series B (Methodological) 10, 243–251.

36.Bivand, RS, Pebesma, EJ and Gómez-Rubio, V. (2013) Applied Spatial Data Analysis with R. In Gentleman, R, Hornik, K & Parmigiani, G. G, Eds., *Use R* (2nd ed., Vol. 1). New York, NY: Springer. doi:10.1007/978-0-387-78171-6.

37.Peleteiro, B, et al. (2014) Prevalence of *Helicobacter pylori* infection worldwide: a systematic review of studies with national coverage. Digestive Diseases and Sciences 59, 1698–1709.

38.Pounder, RE and Ng, D (1994) The prevalence of *Helicobacter pylori* infection in different countries. Alimentary Pharmacology & Therapeutics 9, 33–39.

39.Metcalf, CJE, et al. (2012) Structured models of infectious disease: inference with discrete data. Theoretical Population Biology Elsevier Inc. 82, 275–282.

40.Brisson, M, et al. (2001) Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiology and Infection 127, 305–314.

41.Brisson, M and Edmunds, WJ (2002) The cost-effectiveness of varicella vaccination in Canada. Vaccine 20, 1113–1125.

42.Edmunds, WJ, Brisson, M and Rose, JD (2001) The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19, 3076–3090.

43.Blanchard, TG and Czinn, SJ. (2016) Identification of *Helicobacter pylori* and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease. Pediatric Research 81, 170–176, Published online: 2016. doi: 10.1038/pr.2016.199.